SECANT THERAPEUTICS
Secant Therapeutics, Inc. develops a percutaneous transcatheter direct plication annuloplasty (DPA) device. The company was incorporated in 2010 and is based in Basking Ridge, New Jersey.
SECANT THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
Basking Ridge, New Jersey, United States
Country:
United States
Total Employee:
51+
Status:
Active
Total Funding:
150 K USD
Current Employees Featured
More informations about "Secant Therapeutics"
Secant Therapeutics Company Profile 2024: Valuation, Funding ...
Secant Therapeutics General Information Description. Provider of therapeutic services intended for heart disease. The company caters to the healthcare industry and offers percutaneous …See details»
Secant Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 19, 2011: Seed Round - …See details»
Secant Group - Implantable Medical Textiles, Fabrics, and Polymer ...
Secant embraces your mission to revolutionize medicine by evolving our biomaterials to meet the challenge. By developing textiles, polymers, and hybrids at scale. By combining diverse …See details»
Secant Therapeutics - Contacts, Employees, Board Members
Secant Therapeutics develops a percutaneous transcatheter direct plication annuloplasty (DPA) device.See details»
Secant Therapeutics - Products, Competitors, Financials, …
Secant Therapeutics is a medical device startup focused on building solutions for structural heart disease associated with congestive heart failure. Use the CB Insights Platform to explore …See details»
Secant Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
New Jersey, United States | 50-100. Last update 01 Nov 2024See details»
About Us - Secant Group
As part of the Solesis family of companies, Secant Group works closely with our sister companies, Polyzen, SanaVita Medical and Charter Medical, to provide advanced textiles, polymers, and …See details»
Tissue Engineering - Secant Group
With decades of polymer, biomaterial, and textile experience in implantables, Secant has developed approaches to selecting the most appropriate combination of materials to meet …See details»
Advancing Pharma and Medical Device Development with Novel …
Oct 21, 2021 Secant Group is focused on implementing this new technology across indications, ... which prompted our parent organization, Solesis, to acquire Charter Medical. Charter …See details»
Biora Therapeutics to be delisted from Nasdaq - Investing.com
1 day ago SAN DIEGO, CA - Biora Therapeutics, Inc. (NASDAQ:BIOR), a pharmaceutical company with a market capitalization of just $6 million, is set to be delisted from The Nasdaq …See details»
Director de Applied Therapeutics renuncia, la empresa busca …
1 day ago Applied Therapeutics, con sede en 545 Fifth Avenue, Suite 1400, Nueva York, NY, opera bajo la jurisdicción de Delaware. Las acciones ordinarias de la empresa cotizan en el …See details»
Biora Therapeutics sarà esclusa dal Nasdaq Da Investing.com
2 days ago SAN DIEGO, CA - Biora Therapeutics, Inc. (NASDAQ:BIOR), un'azienda farmaceutica con una capitalizzazione di mercato di soli 6 milioni di dollari, sarà esclusa dal …See details»
Il direttore di Applied Therapeutics si dimette, l'azienda cerca un ...
1 day ago Contemporaneamente, Applied Therapeutics è impegnata nello sviluppo di un trattamento per la Deficienza di Sorbitolo Deidrogenasi, con una presentazione di New Drug …See details»
applied therapeutics director resigns, company seeks replacement
1 day ago Applied Therapeutics, with its headquarters at 545 Fifth Avenue, Suite 1400, New York, NY, operates under the jurisdiction of Delaware. The company's common stock is traded …See details»
Secant Therapeutics - Crunchbase
Secant Therapeutics develops a percutaneous transcatheter direct plication annuloplasty (DPA) device.See details»
4D Molecular Therapeutics emette warrant pre-finanziato a RA …
1 day ago 4D Molecular Therapeutics, Inc., un'azienda biotecnologica specializzata in prodotti di terapia genica con una capitalizzazione di mercato di 320 milioni di dollari, ha stipulato un …See details»
Secant Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Jun 13, 2023 Explore Secant Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
4D Molecular Therapeutics émet un bon de ... - Investing.com France
1 day ago 4D Molecular Therapeutics, Inc., une entreprise de biotechnologie spécialisée dans les produits de thérapie génique avec une capitalisation boursière de 320 millions de dollars, a …See details»
Drug Delivery Resources - Secant Group
Explore articles, data sheets, presentations, and posters about Secant Group’s controlled release platform for drug delivery, Hydralese®, a novel polymer platform for controlled delivery of …See details»
Form 8-K Prelude Therapeutics For: Dec 11 - streetinsider.com
16 hours ago Item 8.01 Other Events. On December 11, 2024, Prelude Therapeutics Incorporated (the "Company") issued a press release announcing the presentation of the first …See details»